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Abstract 112 
Objective: This multicentre cross-sectional study aims to estimate the prevalence of five 113 
neglected tropical diseases (Chagas disease, filariasis, schistosomiasis, strongyloidiasis, 114 
toxocariasis) among immigrants accessing health care facilities in five Italian cities 115 
(Bologna, Brescia, Florence, Rome, Verona).  116 
Methods: Individuals underwent a different set of serological tests, according to country of 117 
origin and presence of eosinophilia. Seropositive patients were treated and further 118 
followed up. 119 
Results: A total of 930 adult immigrants were enrolled: 477 men (51.3%), 445 women 120 
(47.9%), 8 transgender (0.8%); median age was 37.81 years (range 18-80). Most of them 121 
were coming from the African continent (405/930, 43.5%), the rest from East Europe, 122 
South America and Asia. A portion of 9.6% (89/930) were diagnosed with at least one of 123 
the infections under study. Seroprevalence of each specific infection varied from 3.9% 124 
(7/180) for Chagas diseases to 9.7% (11/113) for toxocariasis. Seropositive people were 125 
more likely to be 35 to 40 years-old male and to come from South East Asia, Sub-Saharan 126 
Africa or South America. 127 
Conclusions: The results of our study confirm that neglected tropical diseases represent a 128 
substantial health problem among immigrants and highlight the need for addressing this 129 
emerging public health issue. 130 
 131 
 132 
Introduction 133 
The World Health Organization (WHO) defines the neglected tropical diseases (NTDs) as 134 
a diverse group of infections mainly affecting poor populations, increasing poverty, and 135 
having a low priority in the political and scientific agenda [1].  136 
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Human migration is a key factor in the appearance/re-appearance of NTDs in non or 137 
former endemic contexts [2] [3]. We live in an era of unprecedented human mobility, with 138 
approximately 232 million international migrants and 740 million internal migrants 139 
worldwide [4]: Eurostat estimated that a total of 3.4 million people migrated to one of the 140 
European Community countries in 2013; half of them came from non-member countries 141 
[5]. In 2014, immigrants accounted for the eight per cent of the total Italian resident 142 
population [6]; another 326,000 undocumented immigrants and refugees were present in 143 
Italy. [7]. 144 
Immigrants are generally young and in good health conditions [8], nevertheless, the 145 
prevalence of some infectious diseases may be significant among immigrants, as a result 146 
of the wide diffusion of these conditions in their countries of origin [9] and the further 147 
exposure during migration [10] [3]. Many infections, including several NTDs, may be 148 
asymptomatic and hence remain undiagnosed [11]. As a consequence, seropositive 149 
individuals can develop chronic forms (e.g. Chagas disease, schistosomiasis), fatal 150 
complications (e. g. Chagas disease, schistosomiasis or strongyloidiasis) and can 151 
potentially transmit the disease [11].  152 
The research on the burden of communicable diseases among immigrants in Western 153 
countries mainly focuses on HIV, tuberculosis and viral hepatitis [8] [12]. NTDs were rarely 154 
addressed, possibly because they are often asymptomatic and have a relatively low 155 
transmission in the absence of environmental and biological reservoirs/vectors. Moreover 156 
in most of the European countries there is no systematic mandatory regulation regarding 157 
NTDs reporting and surveillance [13]. Given the considerable immigration flows to Italy 158 
and the scarce information on the relevance of the NTDs, seldom considered at hospital 159 
level, this study aims to estimate the seroprevalence of five NTDs (Chagas disease, 160 
filariasis, schistosomiasis, strongyloidiasis and toxocariasis) among immigrants attending 161 
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hospitals and relative outpatient clinics in five Italian cities: Bologna, Brescia, Florence, 162 
Rome, and Verona.  163 
 164 
 165 
Methods 166 
Study population, data collection and patient management 167 
A cross-sectional survey was performed in five Italian infectious and tropical diseases units 168 
located in five different hospitals (Bologna University Teaching Hospital; Florence 169 
University Teaching Hospital; Hospital Sacro Cuore – Negrar, Verona; Spedali Civili 170 
General Hospital, Brescia; L. Spallanzani University Teaching Hospital, Rome) and in one 171 
outpatient clinic for undocumented immigrants (Brescia Local Health Authority outpatient 172 
clinic). In the hospital setting, patients were usually referred from primary care, Emergency 173 
Departments or other secondary care services; they were either inpatients or individuals 174 
with chronic infections followed-up in specialised outpatient clinics.  175 
Individuals who attended any of the above mentioned centres for any reason in the study 176 
period (November 2012 to November 2014) and who were born in an endemic country 177 
(see online appendix Annex 1 for details), older than 18 years and with sufficient 178 
knowledge of Italian or a timely access to a linguistic mediator, were eligible. In each 179 
clinical centre one or two investigators were responsible for offering participation to the 180 
project to each eligible patient seeking care during any of their routine clinical activities. 181 
After signing the informed consent, enrolled patients underwent a different set of 182 
serological tests according to the criteria reported in online appendix Table 1. The choice 183 
of the infections was based on the most common areas of origin of immigrants in Italy, the 184 
potential severity of the disease if not treated, the availability and quality of diagnostic 185 
tools, the amenability to treatment and the potential for spreading in the community. The 186 
definition of endemic country for a certain infection was based on the WHO geographical 187 
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classification of NTDs [14] (see online appendix Annex 1 for details). For filariasis, only 188 
endemic countries for lymphatic filariasis, onchocerciasis and loiasis were included. 189 
Serology for toxocariasis and filiariasis was limited to individuals with eosinophilia These 190 
two diseases usually present with a raised eosinophil count [15]. However, in order to 191 
increase case detection, eosinophil cut-off level was set at 300/µL instead of 450-500/µL, 192 
as routinely suggested [15], for its good positive predictive value for helminthiases [16].  193 
Concurrently, clinical and socio-demographic information, including country of origin, list of 194 
visited countries, time since arrival, and educational level were collected. The investigators 195 
offered treatment and follow-up to seropositive patients, while they supplied seronegative 196 
individuals with the results of their tests. The centres elaborated operational guidelines for 197 
the management of each disease which were made available on the study website. 198 
Study protocol was approved by the ethics committee of the coordinating site (Bologna 199 
University Teaching Hospital) under the resolution number 124/2012/O/Oss and by those 200 
of all other participating units. 201 
 202 
Microbiological diagnosis procedures 203 
A sample of 12 ml of venous blood was collected from each participant. Blood samples 204 
were centrally tested at the Service of Epidemiology and Laboratory for Tropical Diseases 205 
of the Hospital Sacro Cuore – Don Calabria, Negrar in order to reduce inter-laboratory 206 
variability. Serum samples were tested for specific antibodies using commercial 207 
immunoenzymatic assays according to manufacturer's instructions. The qualitative 208 
presence of antibodies for Trypanosoma cruzi (etiological agent of Chagas disease) was 209 
tested employing two enzyme-linked immunosorbent assays (ELISA), one based on 210 
recombinant antigens (“BioELISA Chagas”, Biokit, Lliça d′Almunt, Spain), the other based 211 
on crude antigens (“BioELISA Chagas III”, BiosChile, Santiago, Chile). For the other 212 
infections a single ELISA was used (“Filariasis ELISA kit”, Bordier Affinity Products SA, 213 
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Crissier, Switzerland, for filariasis; “Schistosoma mansoni ELISA kit”, Bordier Affinity 214 
Products SA, Crissier, Switzerland for schistosomiasis; “Strongyloidiasis ELISA kit” based 215 
on Strongyloides ratti antigens, Bordier Affinity Products SA, Crissier, Switzerland for 216 
stronglyloides; “DRG Toxocara canis ELISA”, DRG Instruments GmbH, Marburg, 217 
Germany, for toxocariasis). 218 
 219 
Statistical analysis  220 
Categorical variables were described through frequencies and the median and the ranges 221 
were used to describe age. Countries of origin were subsequently grouped into 11 regions 222 
following the Geosentinel classification [17]. This choice relies on the fact that Geosentinel 223 
system splits the globe into a higher number of regions (eleven) than WHO (six), with more 224 
precise identification of risk areas. 225 
Prevalence point estimates and their 95% confidence intervals were obtained. Chi-square 226 
tests were performed to assess differences between groups. Data were managed and 227 
analysed using STATA 14.1. 228 
 229 
 230 
Results  231 
Description of the study population 232 
From November 2012 to November 2014 a total of 930 individuals were enrolled across 233 
the six centres. Two thirds of them were outpatients. Due to refused consent or scarce 234 
knowledge of Italian/lack of linguistic mediator, 4.9% (48/978) of the individuals were not 235 
enrolled. 236 
Socio-demographic information of the enrolled population is summarized in online 237 
appendix Table 2. The male-to-female ratio was 1:1, and the median age was 37.8 years 238 
(range 18-80); almost half of the participants had been living in Italy for more than 10 239 
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years. Individuals coming from the African region represented 43.5% of the total (405/930); 240 
other frequent areas of origin were Eastern Europe (197/930, 21.2%), South and Central 241 
America (177/930, 19.0%) and Asia (142/930, 15.3%). More than a half of patients 242 
declared a medium or high level of education (high school diploma or degree). The socio-243 
demographic profile of the individuals varied slightly across the six centres. In the clinic for 244 
undocumented immigrants in Brescia, enrolled subjects were younger than the total 245 
population (median age of 35.2 versus 37.8 years, age range of 18-64 versus 18-80) and 246 
their time since arrival was slightly shorter (50.9%, 56/110, of them arrived in the last four 247 
years versus 31.3%, 290/930, in the total). Differences across the centres in terms of 248 
origin might mirror the differing immigrant flows to the Italian cities: despite the high 249 
presence of African immigrants in the whole sample, individuals enrolled in the Roman 250 
hospital were mainly South Americans and the ones enrolled in Bologna mainly came from 251 
Eastern Europe.  252 
A white blood cell count was available for 583 individuals: among them, 19.4% (113) had 253 
eosinophilia. 254 
 255 
Seroprevalence of the neglected infectious diseases 256 
Among the 930 enrolled individuals, 96 new infections were detected: 42 cases of 257 
strongyloidiasis, 31 of schistosomiasis, 11 of toxocariasis, 7 of Chagas disease, and 5 of 258 
filariasis. Eighty-nine patients were diagnosed with one or more NTDs, which leads to an 259 
overall seroprevalence of 9.6% (95%CI 7.8-11.6) in the study population. Seven 260 
individuals had two infections simultaneously. Across the centres the prevalence varied 261 
between 6.3%, 7/110, (in Brescia clinic for undocumented immigrants) and 15.3%, 30/193, 262 
(in Verona). 263 
Seropositive individuals were mostly men (M:F=2:1) with a median age of 38.8 years 264 
(range 21-78). The seroprevalence was twice as high in men as in women (p-value<0.05) 265 
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for all infections except for Chagas disease. The Geosentinel region with the highest NTDs 266 
prevalence was South East Asia, followed by Sub-Saharan Africa and South America. 267 
Among the 189 patients who were known to be HIV positive, 14 (7.4%) were also 268 
seropositive for at least one of the NTDs under study (8 cases of strongyloidiasis, 4 cases 269 
of schistosomiasis, 2 cases of toxocariasis and 1 case of Chagas disease). 270 
Global seroprevalence, women to men ratio and regions with highest prevalence are 271 
shown in Table 1. Detailed prevalence estimated by infections and Geosentinel regions 272 
are listed in online appendix Table 3. 273 
 274 
Discussion 275 
Approximately one out of 10 individuals in our study was seropositive for at least one of 276 
the infections. This figure represents a considerable burden given the potential 277 
consequences of these conditions. In particular, strongyloidiasis and Chagas disease can 278 
lead to chronic infections, which might represent a serious threat for the individual and the 279 
health systems [18]. Strongyloidiasis is responsible of the hyperinfection syndrome, a rare 280 
life-threatening complication that mainly affects immunosuppressed individuals, thus early 281 
detection and treatment are particularly relevant [19]. Similarly, the potential 282 
transmissibility of Chagas disease outside endemic areas, through blood transfusions, 283 
organ or tissue transplants, or mother-to-child, highlights the importance of its early 284 
detection [20]. Furthermore, most of these infections are treatable with affordable and 285 
generally well-tolerated therapies, especially when compared to the severity of the 286 
untreated consequences [21]. 287 
Interestingly, we noticed a higher prevalence of the five neglected infections among 288 
patients coming from South East Asia, Sub-Saharan Africa and South America, suggesting 289 
that immigrants coming from these areas are most at risk. However, this broad geographic 290 
subdivision may mask differences at country level which we were not able to account for, 291 
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given the limited sample size. The prevalence of all infections was twice as high in men as 292 
in women (p-value<0.05) but Chagas disease. A potential higher environmental and 293 
working exposure risk for intestinal parasites and other vector-borne infections among 294 
male immigrants can contribute to explain this finding [22]. Age and time since arrival in 295 
Italy were not associated with the presence of infections. 296 
These results are in line with the findings of similar studies carried out in Spain [8] [23], 297 
except for Chagas disease prevalence, which was much higher in the Spanish samples. 298 
This difference may be explained by the larger proportion of enrolled Latin American 299 
subjects in the Spanish studies, as a consequence of a different migration pattern and the 300 
availability of widespread screening programs. A cross sectional study carried out in 301 
Australia [11] among recent immigrants and two others conducted in the United States in 302 
refugees [9] [24] reported a higher prevalence of intestinal parasitic infections than in our 303 
study. These figures may be explained by the different population under study and by our 304 
diagnostic approach based on antibody detection. The mentioned studies mainly enrolled 305 
refugees and recent immigrants and used microscopic examination of the stools, 306 
identifying also parasites for which no serological test is available. 307 
As already reported by others [25], we noticed a significant seroprevalence of NTDs in the 308 
subgroup of patients with a known HIV infection. In this subgroup of patients treatment 309 
should be strongly recommended, because of the risk of severe complications especially 310 
in the case of strongyloidiasis and Chagas disease [25]. 311 
In our study, the proportion of individuals with an increased eosinophil count was in line 312 
with other studies [26] [15], despite a possible overestimation due to the lower cut-off level 313 
for an abnormal eosinophil count. Eosinophilia generally occurs in approximately 10% of 314 
individuals returning from the tropics [15], and a prevalence up to 30% is often reported 315 
among immigrant populations [26]. In this last group helminthic infections are the 316 
commonest identifiable cause of eosinophilia, accounting for 14% to 64% of the total 317 
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cases [15]. Among those who were screened for strongyloidiasis, positive patients were 318 
more likely to have a high eosinophil count (data not shown). This result confirms what 319 
was previously found and emphasizes the importance of investigating the presence of S. 320 
stercoralis among immigrants, particularly in presence of raised eosinophil levels [15].  321 
Whilst for Chagas disease and schistosomiasis serology is deemed to be a valid screening 322 
tool [8], there is no standard method for the detection of other intestinal parasites [27]. 323 
When stool microscopy had been used for screening purpose, the prevalence was found 324 
to be relatively low [8] [23]. Amongst intestinal parasites we focused on strongyloidiasis, 325 
because of its potentially fatal complications in immunosuppressed populations and to its 326 
long-term persistence in the host [28].  327 
The main limitation of the study is its generalizability. The enrolment took place at hospital 328 
level and not at the community level; this means that our results may not be entirely valid 329 
for the general immigrant population. Individuals who access the health services may be 330 
those who have been in the host country for a longer time; they may differ from the general 331 
population in terms of socio-demographic characteristics and, therefore, may have a 332 
different risk profile for the infections. Moreover, no formal sample size calculation was 333 
performed; some prevalence estimates on specific infections and subpopulations showed 334 
a great uncertainty due to the small sample size of these groups. 335 
Additionally, a selections bias cannot be ruled out. Enrolment in the study completely 336 
relied on the staff dedicated to the project. It is likely that a proportion of patients eligible 337 
for the study had been missed; however, they should not have been systematically 338 
different from those enrolled because the physicians responsible for the enrolment 339 
covered different care settings within their units. Moreover, not all the patients who were 340 
asked to take part in the study gave their consent. The proportion of patients who did not 341 
participate despite their eligibility was less than five percent in all the centres suggesting 342 
that this source of bias is not substantial. 343 
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Another limitation of the study lies in the exclusive use of serology to estimate the 344 
prevalence of selected NTDs in immigrants. As a matter of facts, these tests may not 345 
distinguish between prior infection and active disease since antibodies may persist for 346 
many months to years after successful treatment in most of the NTDs evaluated and these 347 
tests are prone to cross-reactions with other parasite antigens [29]. Additional tests on 348 
stool or urine samples would have certainly increased the diagnostic sensitivity but were 349 
deemed not be feasible, given the logistic arrangement of the study that relied on a 350 
centralised laboratory. Since the therapies for the infections under study are mostly short-351 
term and well-tolerated, we opted for treating all seropositive patients, except those 352 
affected by T. cruzi infection, who underwent disease staging before treatment according 353 
to current agreements [30]. 354 
Despite these limitations, our findings highlight the importance of tackling the NTDs 355 
challenge in a non-endemic setting. The call for systematic detection and appropriate 356 
management is even more urgent because it has been reported that health professionals 357 
rarely consider these diseases. As a consequence, NTDs are highly likely to be 358 
underdiagnosed at present, or diagnosed too late or inefficiently managed [31]. As 359 
previously suggested in the European context, screening protocols seem to be a sensible 360 
option [32]. A presumptive anthelminthic therapy for immigrants coming from areas at high 361 
risk had been previously demonstrated to be cost effective in certain setting [27]. However, 362 
this approach is not free from drawbacks, including toxicity, under-treatment of certain 363 
infections [33] and risk of focusing on a single medical intervention while neglecting a 364 
proper follow-up and a more comprehensive approach to migrants’ health. 365 
The importance of diagnosing and treating these infections is crucial among 366 
immunosuppressed patients (for example those receiving chemotherapy, chronic steroid 367 
or immunosuppressive treatment) and donors/recipients of solid organ and hematopoietic 368 
stem cell transplantation, as well as blood transfusion [34]. Indeed, the rising success and 369 
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adoption of transplantation reasonably increases the proportion of the immigrant 370 
population who will become donor/recipient of organ transplantation and 371 
blood/hemoderivates in destination countries. Many of the pathogens that cause NTDs can 372 
be either reactivated during immunosuppression or transmitted via organ graft or blood 373 
transfusions [34], making a screening approach in these contexts life-saving. 374 
 375 
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Numerator and 
denominator 
Overall prevalence 
(95% CI)  
Women to 
men ratio 
Geosentinel Regions with highest prevalence                                                                  
Geosentinel Region 
Numerator and 
denominator 
Region-specific 
prevalence (95% CI) 
Strongyloidiasis 42/939  4.51% (3.35-6.05) 1:2 
North East Asia 2/31 6.45% (1.48-23.93) 
Sub-Saharan Africa 20/330 6.06% (3.93-9.22) 
South Central Asia 5/90 5.55% (2.29-12.85) 
Schistosomiasis 31/519 5.97% (4.22-8.37) 1:2.8 
Sub-Saharan Africa 25/323 7.73% (5.27-11.22) 
South America 3/46 6.52% (2.02-19.05) 
South Central Asia 1/34 2.94% (0.37-19.77) 
Chagas disease 7/180 3.88% (1.85-7.98) 2.5:1 South America* 7/172  4.06% (1.93-8.34) 
Toxocariasis 11/113 9.73% (5.42-16.86) 1:1.8 
South East Asia 2/6 33.33% (4.18-85.13) 
South America 4/19 21.05% (7.33-47.32) 
Eastern Europe 3/24 6.89% (3.73-34.48) 
Filariasis 5/54  9.25% (7.83-11.63) 1:1.5 Sub-Saharan Africa* 5/34 14.70% (5.96-31.91) 
* Only one region is reported because the infection was not found in people coming from other areas 
  
